Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / ADR
-
Shares outstanding
-
50.2M
-
Number of holders
-
153
-
Total 13F shares, excl. options
-
41.2M
-
Shares change
-
+3.85M
-
Total reported value, excl. options
-
$2.68B
-
Value change
-
+$247M
-
Put/Call ratio
-
0.18
-
Number of buys
-
92
-
Number of sells
-
-50
-
Price
-
$65.00
Significant Holders of Immunocore Holdings plc - ADR (IMCR) as of Q1 2024
179 filings reported holding IMCR - Immunocore Holdings plc - ADR as of Q1 2024.
Immunocore Holdings plc - ADR (IMCR) has 153 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 41.2M shares
of 50.2M outstanding shares and own 82.04% of the company stock.
Largest 10 shareholders include RTW INVESTMENTS, LP (6.02M shares), WELLINGTON MANAGEMENT GROUP LLP (5.75M shares), FMR LLC (4.31M shares), PRICE T ROWE ASSOCIATES INC /MD/ (2.44M shares), Rock Springs Capital Management LP (2.37M shares), Paradigm Biocapital Advisors LP (1.79M shares), BAKER BROS. ADVISORS LP (1.52M shares), GENERAL ATLANTIC, L.P. (1.51M shares), Bellevue Group AG (972K shares), and Logos Global Management LP (900K shares).
This table shows the top 153 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.